Log In
BCIQ
Print this Print this
 

bamosiran (SYL040012)

  Manage Alerts
Collapse Summary General Information
Company Sylentis S.A.
DescriptionShort interfering RNAs (siRNAs) directed against adrenergic receptor beta 2 (ADRB2)
Molecular Target Adrenergic receptor beta 2 (ADRB2)
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA: siRNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today